Loading stock data…
$8.25-0.14 (-1.67%)
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.
electroCore, Inc. in the Healthcare sector is trading at $8.25 with a market capitalization of $74M. Wall Street consensus targets $19.17 (5 analysts), implying a +132.4% move over the next 12 months. The stock is currently 35% below its 52-week high of $12.70, remaining 8.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 4 is oversold, raising the odds of a near-term bounce. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.45M↓ | $9.58M↑ | $9.24M↑ | $8.69M↑ | $7.38M |
| Gross Profit | $8.18M↓ | $8.36M↑ | $8.17M↑ | $7.47M↑ | $6.44M |
| Operating Income | -$2.77M↑ | -$5.32M↓ | -$2.94M↓ | -$2.88M↑ | -$3.51M |
| Net Income | -$3.06M↑ | -$5.27M↓ | -$3.04M↑ | -$3.40M↑ | -$3.67M |
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCor...